CENTRAL LABORATORIES FEATURED ARTICLES
CENTRAL LABORATORIES WHITE PAPERS & ARTICLES
-
![AI medical cloud technology, analyzing patient health data, artificial intelligence agents, smart medical records, digital healthcare solutions-GettyImages-2229247291]( "Tech-Enabled FSP Delivery")
Tech-Enabled FSP DeliveryStruggling with data silos and delayed trial visibility? See how combining AI with smarter data integration helps teams gain real-time visibility without adding headcount.
-
![data-cleaning-clinical-trialls]( "AI in Clinical Trials: 5 Practical TrialKit Use Cases for Data Management")
AI in Clinical Trials: 5 Practical TrialKit Use Cases for Data ManagementAI is improving daily data management with automation, faster issue detection, and smarter reviews. This piece outlines practical use cases and what teams need to enable real, sustainable adoption.
-
![GettyImages-1404668261 data, technology]( "From Data Capture To Clinical Intelligence: How AI Is Expanding EDC In Clinical Trials")
From Data Capture To Clinical Intelligence: How AI Is Expanding EDC In Clinical TrialsModern electronic data capture (EDC) systems are transforming clinical trials by evolving from data repositories into dynamic clinical intelligence hubs.
-
![AI, artificial intelligence IOT-GettyImages-2186052234]( "Your 6-Step Path To AI-Ready Data")
Your 6-Step Path To AI-Ready DataStruggling with siloed or inconsistent trial data? This guide outlines a clear path to cleaner, governed, AI-ready datasets.
-
![GettyImages-1026593952 tablet, data]( "The FSP Model Tailored For Biotech")
The FSP Model Tailored For BiotechAs biomarker-driven trial designs and protocol complexity intensify, small and mid-sized sponsors face a growing gap between ambition and operational capacity that fragmented outsourcing can't close.
CENTRAL LABORATORIES APPLICATIONS & STUDIES
-
Stabilizing A Biotech Sponsor's Data Management And Biostatistics Functions8/29/2026
Discover how a rapid mid-study data transition rescued an endangered clinical trial, cleaned up compromised data, and secured a critical interim database lock within twelve months.
-
Driving ROI: A Real-Time Clinical Trial Oversight Solution8/3/2026
Sample errors, delays, and query overload drain clinical trial budgets. Learn how real-time data capture can shorten timelines and protect data quality.
-
Accelerating A Schizophrenia Trial While Ensuring Quality7/31/2026
Tight timelines and rising patient targets don't have to derail a trial. See how speed and data quality can work together from enrollment to database lock.
-
Reserving Data Integrity With Retrospective Manual Entry7/5/2026
A look at implementing randomization mid-trial by reconstructing subject and inventory records without disrupting sites or compromising data integrity.
-
A Mission To Expand Recruitment Territory6/11/2026
Learn how a proactive feasibility approach helps sponsors strengthen enrollment forecasting, mitigate risk, and implement timely interventions that improve study execution and clinical development.
CENTRAL LABORATORIES PRODUCTS & SERVICES
At Ideagen, we're committed to empowering seamless collaboration and enhancing your document review process. Through strategic alliances with leading technology providers across the life science industry, we offer integrations that amplify the efficiency and effectiveness of your workflows.
Shape crucial market choices and value substantiation with the depth and breadth of integrated clinical EHRs, claims, and patient reported outcome data, backed by analytical and therapy area expertise.
Navigating drug safety in the era of innovation-driven medicine
The focus on drug safety and pharmacovigilance has never been more intense. Patient safety remains paramount throughout a product's lifecycle, even as sponsors and marketing authorization holders (MAHs) face increasing complexity in managing safety data. This complexity stems from huge volumes of data generated from scores of diverse sources, much of it rapidly expanding unstructured data. Innovation-driven medicine is a key factor. These dynamics are reshaping the landscape of drug safety, presenting both challenges and opportunities for innovation in pharmacovigilance practices.
Enabling organizations of all sizes to transform their business through better use of technology.
Avance Clinical’s data management team has gained a world-class reputation for accuracy, precision, and quality of their biostatistics and pharmacokinetic (PK) analysis.
Ideagen Quality Management is a modular SaaS solution designed with the needs of quality managers in mind. Trusted by more than 6,000 customers worldwide to digitalize their quality management processes and comply with industry standards.
CENTRAL LABORATORIES SOLUTIONS
- Drive Automation And Efficiency In Your Interim Lock Process
- Leverage AI To Optimize Protocol Design & Study Start-Up
- De-Risk Randomization With The Endpoint Biostatistical Approach
- Starting A New Study? This One's For You
- Real-World Data And Real-World Evidence
- Medidata Decentralized Clinical Trials (DCT) Program
- TrialKit AI Timeline Value
- Vaccine Solution
- Modernize Clinical Research With Continuous Digital Data
- Unlock Your Clinical Imaging Data Potential
VIDEOS
- Accelerated Recruitment Through AI-Powered Patient Matching At Network Scale
- Endpoint Named A Leader In Everest Group's 2025 Life Sciences RTSM Products PEAK Matrix Assessment
- Human Abuse Potential: Subjective Ratings
- Human Abuse Potential: Participant Recruitment
- Why Now? The Case For Disruptive Technology In Clinical Trials
NEWS
- Avance Clinical Appoints Inaugural Chief Commercial Officer, Reinforcing Global Growth Strategy
- Ypsomed Opens Production Site In China
- Ypsomed Launches YpsoLoop As The First Autoinjector Platform Designed For Circularity
- Ypsomed Expands Offering For Clinical Studies
- Ypsomed Receives The Red Dot Design Award 2026 For YpsoLoop
- Ypsomed Receives FDA Clearance For SmartPilot
- Signant Health Acquires Ametris To Create An End-To-End eCOA And Wearables Platform
- Avance Clinical Announces Asia Pacific And Mainland China Expansion Ahead Of BIO International Convention 2026
- The Ottawa Hospital's Biotherapeutics Manufacturing Centre (BMC) Makes Breakthroughs Break Through As Boreal Biomanufacturing
- Suvoda Patient App Earns "Best Patient Relationship Management Solution" In 2026 MedTech Breakthrough Awards Program
- Quotient Sciences Advances AI-Designed Drug Product Into Clinical Development
- Paradigm Health Announces Collaboration With The FDA To Transform Regulatory Review Of Clinical Trial Data
- Inside Information: Nanoform Signs First Exclusivity Agreement For Ultra-High Concentration Subcutaneous Delivery
- Suvoda Announces Agentic RTSM, Enabling The Reduction Of Clinical Trial Startup Timelines By Up To 80%
- Signant Health Enters Definitive Agreement To Acquire Ametris
- Crucial Data Solutions Expands TrialKit AI With Study Simulation And Validation Capabilities
- AI HealthTech Pioneer Biorce Opens U.S. Offices In Austin To Accelerate Global Expansion
- Signant Health Appoints Specialist Physician And Clinical Research Expert Dr. Graham C. Ellis As Clinical Vice President To Strengthen Metabolic Disease And Diabetes Trial Capabilities
- Suvoda Advances Clinical Trial Financial Planning With Support For Complex Multi-Payee Budgets
- Suvoda Named "Most Innovative Clinical Trial Technology Firm Of 2026"
- Avance Clinical Appoints Liahna Toy To Lead Global Early Phase Center Of Excellence
- Avance Clinical Strengthens Global Oncology Offering With Acquisition Of U.S-Based LumaBridge
- Health Equity Research Goes Global—Without Waiting For Perfect Data
- International Study Confirms Universal Digital Health Framework
- ISPOR Announces New Executive Director
- Quotient Sciences Extends Commercial Manufacturing Partnership For Ultra-Rare Disease Treatment
- Sygnature Discovery Unveils Strategic Rebrand To Cement Status As A Global Drug Discovery Partner
- Suvoda Sets New Standard For Streamlined Patient And Site Experience In Clinical Trials
- Suvoda IRT Named A Leader In Everest Group's RTSM PEAK Matrix®
- Altasciences Announces Chris Perkin Appointed To Board Of Directors; Marie-Hélène Raigneau Appointed Chief Executive Officer